Pirfenidone for treating chronic pancreatitis pain
Treatments studied
Part of Digestive system clinical trials.
This study tests whether the drug pirfenidone can help reduce pain and inflammation in people with chronic pancreatitis. If you have had ongoing pain or frequent flares, this treatment might help calm the inflammation and improve your quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have a confirmed diagnosis of chronic pancreatitis, based on imaging (CT or MRI) showing signs like calcifications or other clear changes.
- You have had significant pancreatic pain (at least 4 out of 10) in the past 3 months, or you have had one or more pancreatitis flares in the past 6 months.
- You have not had pancreatic procedures (like endoscopy, surgery, or nerve blocks) in the last 3 months.
- You do not have serious liver, heart, or kidney problems, and you are not on home oxygen.
- You are willing to follow the study schedule and use effective birth control if you are a woman who can become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new stem cell treatment can reduce the pain of chronic pancreatitis. It aims to improve your quality of life by easing long-term pain.
This Phase 1 study tests a new cell-based treatment to reduce pain caused by chronic pancreatitis. It’s designed mainly to check safety first, and it may help people with ongoing, opioid-stable pancreatic pain.
This study uses a special pain-testing method to better predict how people with chronic pancreatitis-related pain (or similar conditions) will respond to treatment. It may help doctors choose therapies that work better for each person’s type of pain.
This study is testing a new questionnaire to better measure pain in people with chronic pancreatitis. It aims to help doctors understand and treat your pain more effectively.
This early-phase study tests whether simvastatin can improve patient-reported symptoms in people with recurrent acute or chronic pancreatitis. It’s meant to see if the medicine is tolerable and helps with how you feel day to day.
This study looks at how chronic pancreatitis pain affects the nervous system and mental health. It aims to understand pain better and may help develop new ways to manage it.
Hear when a new Chronic Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.